Business Wire India Revenue for the Pharmaceuticals grows by 29% in FY22, with strong expansion in Gross Margins PAT up 25% YoY Balaxi Pharmaceuticals Limited (Balaxi), a branded IPR-based pharmaceutical company headquartered in Hyderabad, reported its results for the quarter and full year ended March 31, 2022. Financial Highlights: Particulars (INR Crore) FY22 FY21 YoY Revenue 279.39 231.33 +20.8% Gross Profit 83.79 59.19 +41.6% […]
Olectra Greentech has received upgradation in credit ratings from ICRA as under: Long Term Cash Credit (Rs 60 crore)- ICRA A-; Stable Long Term/ Short Term Non-fund Based (Rs 265 crore)- ICRA A-; Stable/ ICRA A2+; Stable Short Term Non-fund Based, Derivative Limits (Rs 5 crore) – ICRA A2+ Short Term Non-Fund Based, Letter of Credit (Rs 170 crore) – ICRA A2+Powered by Capital Market […]
Sales decline 3.18% to Rs 42.56 crore
Sales rise 101.03% to Rs 5.85 crore
Sales rise 23.58% to Rs 18.45 crore
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2026, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132 (Member ID - NSE: 10975 BSE: 179 MCX: 55995 NCDEX: 01249), DP SEBI Reg. No. IN-DP-185-2016, PMS SEBI Regn. No: INP000002213, IA SEBI Regn. No: INA000000623, Merchant Banker SEBI Regn. No. INM000010940, RA SEBI Regn. No: INH000000248, BSE Enlistment Number (RA): 5016, AMFI-Registered Mutual Fund Distributor & SIF Distributor
ARN NO : 47791 (Date of initial registration – 17/02/2007; Current validity of ARN – 08/02/2027), PFRDA Reg. No. PoP 20092018, IRDAI Corporate Agent (Composite) : CA1099
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
